NERV Minerva Neurosciences, Inc
$2.21▼ -0.90%
Healthcare
Other
After hours
$2.20▼ -0.58%
Oct 28, 4:46 PM ET
Volume 204.2K
Avg Volume (10D) 158.6K
Key Metrics & Fundamentals
Market Cap
$105.52M
P/E Ratio
–
Div Yield
0.00%
52W Range
2.12 - 8.80
% vs 50 MA
-38.44%
% vs 200 MA
-55.08%
RSI-14
26.7
MACD Histogram
+0.0000
Beta (1Y vs SPY)
1.58
Free Cash Flow
-$13.34M
Gross Rev
$0
Gross Profit
$0
EBITDA
-$38.75M
COGS
–
Operating Exp
$10.64M
Operating Income
-$10.64M
EBIT
-$10.64M
Pretax Income
$17.47M
Net Income
$17.47M
EPS (Diluted)
-0.14
Price & Volume History
Loading chart…
Recent News
Minerva Neurosciences to Host In-Person KOL Event to Discuss Roluperidone for Negative Symptoms of Schizophrenia
GlobeNewswire · Oct 28, 2026 7:00 AM ET
Minerva Neurosciences to Participate in Two Upcoming Investor Conferences
GlobeNewswire · Aug 28, 2026 8:00 AM ET
Minerva Neurosciences: Q2 Earnings Snapshot
Associated Press · Aug 7, 2026 7:20 AM ET
Minerva Neurosciences Provides Second Quarter 2026 Financial Results and Business Updates
GlobeNewswire · Aug 7, 2026 7:00 AM ET
Financial Overview - Income Statement
Quarterly
No financial data available. Click Refresh on the ticker to load latest fundamentals.
See NERV's money flow as a full page
Social Sentiment
Loading Reddit posts…
AI Analysis
Click Generate Analysis for an AI-powered summary, bull & bear case, and recent performance review.
Not financial advice.
All data, scores, charts, and analysis on this site are provided for informational and educational
purposes only and do not constitute financial, investment, legal, or tax advice.
Past performance is not indicative of future results.
See our Legal Notice for full details.